Cigna Group (NYSE: CI) director reports phantom stock unit deferral on Form 4

Rhea-AI Filing Summary

The Cigna Group director reports a routine deferred compensation transaction. On 11/28/2025, the director converted part of a cash retainer into 108.1939 phantom stock units under Cigna’s Deferred Compensation Plan of 2005 for Directors. Each phantom stock unit is the economic equivalent of one share of The Cigna Group’s common stock and will be settled in cash rather than stock.

After this transaction, the director beneficially owns 1,690.8366 phantom stock units, which includes 8.0936 units acquired through the plan’s dividend reinvestment feature. This filing reflects compensation deferral choices rather than an open‑market trade in Cigna common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kurian George

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	108.194	$108.1939	$12K

Holdings After Transaction: Phantom Stock Units — 1,690.837 shares (Direct)

Footnotes (1)

1. Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. Includes 8.0936 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kurian George

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CT 06002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	(1)	11/28/2025		A		108.1939		(1)	(1)	Common Stock, $.01 Par Value	108.1939	$108.1939	1,690.8366	D(2)

Explanation of Responses:

1. Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

2. Includes 8.0936 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Remarks:

	/s/ Jill M. Stadelman, attorney-in-fact	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cigna Group (CI) disclose in this Form 4 filing?

A Cigna Group director reported electing to defer part of a cash retainer into 108.1939 phantom stock units under the company’s director deferred compensation plan.

What are phantom stock units in Cigna Group’s (CI) director plan?

Cigna explains that each phantom stock unit is the economic equivalent of one share of The Cigna Group’s common stock, but the units will be settled in cash.

How many phantom stock units does the Cigna (CI) director hold after this transaction?

Following the reported activity, the director beneficially owns 1,690.8366 phantom stock units under the deferred compensation arrangement.

Did the Cigna Group (CI) director buy or sell actual common stock in the market?

The filing shows a deferral of cash compensation into a hypothetical stock fund as phantom stock units, rather than an open‑market purchase or sale of Cigna common shares.

What role does dividend reinvestment play in the Cigna (CI) phantom units balance?

The total includes 8.0936 phantom stock units that were acquired via a dividend reinvestment feature of the Deferred Compensation Plan of 2005 for Directors.

Is this Cigna Group (CI) Form 4 filed by one or multiple reporting persons?

The document indicates that the Form 4 is filed by one reporting person, who serves as a director of The Cigna Group.